Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors.

Aspirin Dosing for Secondary Prevention of Atherosclerotic Cardiovascular Disease in Patients Treated With P2Y12 Inhibitors. J Am Heart Assoc. 2023 10 17; 12(20):e030385.

View in: PubMed

subject areas

Acute Coronary Syndrome
Aspirin
Atherosclerosis
Cardiovascular Diseases
Hemorrhage
Humans
Platelet Aggregation Inhibitors
Prasugrel Hydrochloride
Purinergic P2Y Receptor Antagonists
Secondary Prevention
Ticlopidine

authors with profiles

Tamar S. Polonsky